(Q45947801)

English

Signaling pathways involved in DNA synthesis and migration in response to lysophosphatidic acid and low-density lipoprotein in coronary artery smooth muscle cells.

scientific article published in May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Signaling pathways involved in DNA synthesis and migration in response to lysophosphatidic acid and low-density lipoprotein in coronary artery smooth muscle cells. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

author name string

Mayumi Komachi

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Alatangaole Damirin

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Enkhzol Malchinkhuu

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Chihiro Mogi

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Masayuki Tobo

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Hideo Ohta

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Koichi Sato

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Hideaki Tomura

8

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Fumikazu Okajima

9

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

publication date

1 May 2009

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Vascular Pharmacology

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

50

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

5-6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

178-184

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Antiinflammatory properties of HDL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

NFAT signaling: choreographing the social lives of cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Role of lipoprotein-associated lysophospholipids in migratory activity of coronary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Metalloprotease-dependent ErbB ligand shedding in mediating EGFR transactivation and vascular remodelling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Lysophospholipid receptors: signaling and biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Remnant Lipoprotein-Induced Smooth Muscle Cell Proliferation Involves Epidermal Growth Factor Receptor Transactivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Oxidized phospholipids as modulators of inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Phosphatidylinositol 3-Kinase and Calcium-Activated Transcription Pathways Are Required for VLDL-Induced Smooth Muscle Cell Proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Molecular regulation of HDL metabolism and function: implications for novel therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Evidence that lipoproteins are carriers of bioactive factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Regulation and biological activities of the autotaxin-LPA axis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Trans-regulation of epidermal growth factor receptor by lysophosphatidic acid and G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Mechanisms of lysophosphatidic acid-induced DNA synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Phosphoinositide 3-kinases in lysophosphatidic acid signaling: regulation and cross-talk with the Ras/mitogen-activated protein kinase pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

A potential role for nuclear factor of activated T-cells in receptor tyrosine kinase and G-protein-coupled receptor agonist-induced cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Lysophosphatidic acid induces neointima formation through PPARgamma activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.01.004

7 January 2021

Identifiers

10.1016/J.VPH.2009.01.004

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19563736

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45947801&oldid=1369746312"